THCBF – OTC
VANCOUVER, BC January 25, 2021 / PRNewswire / – THC BioMed Intl Ltd. (“THC BioMed” or the “Company”) is pleased to announce that Fundamental Research Corp. initiated independent reporting on investment research on THC BioMed.
Fundamental Research Corp. is an independent research house paid for by the issuer. THC BioMed takes note of this development for informational purposes only and endorses the content of the report by Fundamental Research Corp. Not.
THC BioMed is a licensed producer of medicinal cannabis and recreational cannabis under the Cannabis Act. It is licensed to grow and sell dried, extracted, edible, and topical cannabis. The company is a leader in scientific research and the development of products and services in the medical cannabis industry. Management believes THC BioMed is well positioned to be at the forefront in this fast growing industry.
This press release may contain forward-looking information within the meaning of Canadian securities legislation regarding THC BioMed’s business. Forward-looking information is based on certain key expectations and assumptions of the management of THC BioMed. In some instances, you can identify forward-looking statements by the use of words such as “will,” “may,” “dignity,” “expect,” “intend,” “plan,” “seek,” “anticipate.” “believe”, “estimate”, “predict”, “potentially”, “continue”, “likely”, “might” and variations of these terms and similar expressions or the negative of these terms or similar expressions. Forward-looking statements in this press release speak as of the date of this press release and include that THC BioMed will be at the forefront of this fast growing industry. While THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should be placed on the forward-looking information, as THC BioMed makes no representation that it will prove to be correct. THC disclaims any intention or obligation to publicly update any forward-looking information, whether as a result of new information, future events or results, or otherwise than required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and assumes no responsibility for the adequacy or accuracy of the contents of this press release.
SOURCE THC BioMed